uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted September 16, 2016

Memory Enhancement Ingredient Vinpocetine Should Not Be Sold In Supplements, Says FDA

On September 7, 2016, the FDA announced its tentative conclusion that the synthetic compound vinpocetine, currently sold in some dietary supplements, should not be classified as a dietary supplement ingredient. The agency is seeking comments for consideration as it works to make a final decision on the regulatory status of the chemical.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at